12 / 23
Page 52
allied
academies
August 17-18, 2017 | Toronto, Canada
ANNUAL BIOTECHNOLOGY CONGRESS
Ann Biol Sci, 2017
ISSN: 2348-1927
P
lant made biologics have elicited much attention
over recent years for their potential to assist those in
developing countries who have poor access to modern
medicine. Vaccines and other biopharmaceuticals derived
from plants are inexpensive, lack refrigeration requirements
and can be produced en masse in a relatively short period
of time. Pharmaceuticals developed in this fashion could be
utilized for functions ranging from defense against infectious
diseases that have pandemic potential, such as influenza or
Ebola virus, to combating orphan diseases which are poorly
funded yet remain paramount to global health in their
respective endemic regions. Biopharmaceuticals have been
generated via many plant production platforms, including
stable expression in transgenic plants, suspension cell
cultures and hairy roots, as well as transiently using plant
virus expression vector technologies. The presentation will
provide an overview of plant-derived pharmaceuticals and
will conclude with a projection of the impact they could have
for developing countries.
e:
klh22@cornell.eduPlant made pharmaceuticals for developing countries
Kathleen Hefferon
University of Toronto, Canada
Ann Biol Sci, 2017, 5:3
DOI: 10.21767/2348-1927-C1-003